Terms: = Breast cancer AND SDHB, PGL4, 6390, ENSG00000117118, SDH1, SDHIP, SDH, IP
484 results:
1. OMA1 competitively binds to HSPA9 to promote mitophagy and activate the cGAS-STING pathway to mediate GBM immune escape.
Zhu W; Rao J; Zhang LH; Xue KM; Li L; Li JJ; Chen QZ; Fu R
J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38604814
[TBL] [Abstract] [Full Text] [Related]
2. Causal relationship between inflammatory cytokines and autoimmune thyroid disease: a bidirectional two-sample Mendelian randomization analysis.
Yao Z; Guo F; Tan Y; Zhang Y; Geng Y; Yang G; Wang S
Front Immunol; 2024; 15():1334772. PubMed ID: 38571956
[TBL] [Abstract] [Full Text] [Related]
3. Regulator of Ribosome Synthesis 1 (RRS1) Stabilizes GRP78 and Promotes breast cancer Progression.
Sun W; Song J; Wu Q; Deng L; Zhang T; Zhang L; Hua Y; Cao Y; Hou L
Molecules; 2024 Feb; 29(5):. PubMed ID: 38474562
[TBL] [Abstract] [Full Text] [Related]
4. Deubiquitinase BRCC3 promotes the migration, invasion and EMT progression of colon adenocarcinoma by stabilizing MET expression.
Feng X; He S; Chen Y; Zhang L
Genes Genomics; 2024 May; 46(5):637-646. PubMed ID: 38470543
[TBL] [Abstract] [Full Text] [Related]
5. Methylation of GPRC5A promotes liver metastasis and docetaxel resistance through activating mTOR signaling pathway in triple negative breast cancer.
Ou X; Tan Y; Xie J; Yuan J; Deng X; Shao R; Song C; Cao X; Xie X; He R; Li Y; Tang H
Drug Resist Updat; 2024 Mar; 73():101063. PubMed ID: 38335844
[TBL] [Abstract] [Full Text] [Related]
6. DNAJC12 causes breast cancer chemotherapy resistance by repressing doxorubicin-induced ferroptosis and apoptosis via activation of AKT.
Shen M; Cao S; Long X; Xiao L; Yang L; Zhang P; Li L; Chen F; Lei T; Gao H; Ye F; Bu H
Redox Biol; 2024 Apr; 70():103035. PubMed ID: 38306757
[TBL] [Abstract] [Full Text] [Related]
7. Short peptides based on the conserved regions of MIEN1 protein exhibit anticancer activity by targeting the MIEN1 signaling pathway.
Tripathi AK; Desai PP; Tyagi A; Lampe JB; Srivastava Y; Donkor M; Jones HP; Dzyuba SV; Crossley E; Williams NS; Vishwanatha JK
J Biol Chem; 2024 Mar; 300(3):105680. PubMed ID: 38272230
[TBL] [Abstract] [Full Text] [Related]
8. Fbxw7 suppresses carcinogenesis and stemness in triple-negative breast cancer through CHD4 degradation and Wnt/β-catenin pathway inhibition.
Xiao G; Lu W; Yuan J; Liu Z; Wang P; Fan H
J Transl Med; 2024 Jan; 22(1):99. PubMed ID: 38268032
[TBL] [Abstract] [Full Text] [Related]
9. A Nomogram and Risk Classification System Predicting the Prognosis of Patients with De Novo Metastatic breast cancer Undergoing Immediate breast Reconstruction: A Surveillance, Epidemiology, and End Results Population-Based Study.
Zhao J; Bian S; Di X; Xiao C
Curr Oncol; 2023 Dec; 31(1):115-131. PubMed ID: 38248093
[TBL] [Abstract] [Full Text] [Related]
10. PFKP deubiquitination and stabilization by USP5 activate aerobic glycolysis to promote triple-negative breast cancer progression.
Peng ZM; Han XJ; Wang T; Li JJ; Yang CX; Tou FF; Zhang Z
Breast Cancer Res; 2024 Jan; 26(1):10. PubMed ID: 38217030
[TBL] [Abstract] [Full Text] [Related]
11. USP46 enhances tamoxifen resistance in breast cancer cells by stabilizing PTBP1 to facilitate glycolysis.
Gao S; Wang Y; Xu Y; Liu L; Liu S
Biochim Biophys Acta Mol Basis Dis; 2024 Mar; 1870(3):167011. PubMed ID: 38176460
[TBL] [Abstract] [Full Text] [Related]
12. Protein disulfide isomerase family member 4 promotes triple-negative breast cancer tumorigenesis and radiotherapy resistance through JNK pathway.
Tao J; Xue C; Cao M; Ye J; Sun Y; Chen H; Guan Y; Zhang W; Zhang W; Yao Y
Breast Cancer Res; 2024 Jan; 26(1):1. PubMed ID: 38167446
[TBL] [Abstract] [Full Text] [Related]
13. TC2N inhibits distant metastasis and stemness of breast cancer via blocking fatty acid synthesis.
Hao XL; Lv YF; Li DF; Bai FH; Gong J; Pan GQ; Su LX; Wang YL; Fu WL; Liu B; Huang L; Yan D; Tan QL; Liu JY; Guo QN
J Transl Med; 2024 Jan; 22(1):6. PubMed ID: 38167440
[TBL] [Abstract] [Full Text] [Related]
14. Proteomic Analysis Revealed the Potential Role of MAGE-D2 in the Therapeutic Targeting of Triple-Negative breast cancer.
Shi X; Liu C; Zheng W; Cao X; Li W; Zhang D; Zhu J; Zhang X; Chen Y
Mol Cell Proteomics; 2024 Jan; 23(1):100703. PubMed ID: 38128647
[TBL] [Abstract] [Full Text] [Related]
15. Estrogen receptor beta suppresses the androgen receptor oncogenic effects in triple-negative breast cancer.
Xu F; Xu K; Fan L; Li X; Liu Y; Yang F; Zhu C; Guan X
Chin Med J (Engl); 2024 Feb; 137(3):338-349. PubMed ID: 38105538
[TBL] [Abstract] [Full Text] [Related]
16. SCEL regulates switches between pro-survival and apoptosis of the TNF-α/TNFR1/NF-κB/c-FLIP axis to control lung colonization of triple negative breast cancer.
Chan SH; Kuo WH; Wang LH
J Biomed Sci; 2023 Nov; 30(1):93. PubMed ID: 38037106
[TBL] [Abstract] [Full Text] [Related]
17. Assessing serum cytokine profiles in inflammatory breast cancer patients using Luminex® technology.
Bessaad M; Habel A; Hadj Ahmed M; Xu W; Stayoussef M; Bouaziz H; Hachiche M; Mezlini A; Larbi A; Yaacoubi-Loueslati B
Cytokine; 2023 Dec; 172():156409. PubMed ID: 37918053
[TBL] [Abstract] [Full Text] [Related]
18. USP10 promotes the progression of triple-negative breast cancer by enhancing the stability of TCF4 protein.
Yang JR; Lu YB; Su HX; Xiao Y; Pan Q; Su F; Zhang XB; Zhu KL; Guan QL; Ling XL
Biochem Pharmacol; 2023 Dec; 218():115864. PubMed ID: 37863330
[TBL] [Abstract] [Full Text] [Related]
19. NAA20 recruits Rin2 and promotes triple-negative breast cancer progression by regulating Rab5A-mediated activation of EGFR signaling.
Qiao L; Dong C; Jia W; Ma B
Cell Signal; 2023 Dec; 112():110922. PubMed ID: 37827343
[TBL] [Abstract] [Full Text] [Related]
20. Enhanced spectral resolution for correlated spectroscopic imaging using inner-product and covariance transform: a pilot analysis of metabolites and lipids in breast cancer in vivo.
Joy A; Thomas MA
Sci Rep; 2023 Oct; 13(1):16809. PubMed ID: 37798319
[TBL] [Abstract] [Full Text] [Related]
[Next]
